Biotech | October 26, 2021
Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity
Support from DFC will help produce one billion vaccine doses by the end of 2022
Support from DFC will help produce one billion vaccine doses by the end of 2022
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
This unique record was made possible by collating hard copies of the books in a structured manner
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Subscribe To Our Newsletter & Stay Updated
